MARIANNE SAITZ: Open Payments
NPI 1164424172 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$622 in 27 payments from 12 companies in 2025. Trend: 2023 $223 · 2024 $121 · 2025 $622
Food & beverage: $622
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 4 | $135 |
| Alkermes, Inc. | 5 | $112 |
| Janssen Pharmaceuticals, Inc | 3 | $73 |
| Teva Pharmaceuticals USA, Inc. | 2 | $67 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| Neurocrine BioSciences, Inc. | 2 | $46 |
| Neos Therapeutics, LP | 2 | $29 |
| Corium, LLC | 2 | $25 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
Products named: FANAPT, ARISTADA, SPRAVATO, INGREZZA, AUSTEDO XR, EXXUA, UZEDY, Azstarys.
Industry payments across AL — which companies pay providers there.
